Cargando…

Ocular TGF-β, Matrix Metalloproteinases, and TIMP-1 Increase with the Development and Progression of Diabetic Retinopathy in Type 2 Diabetes Mellitus

Diabetic retinopathy (DR) is a sight-threatening late complication of diabetes mellitus (DM). Even though its pathophysiology has not been fully elucidated, several studies suggested a role for transforming growth factor- (TGF-) β, matrix metalloproteinases (MMPs), and tissue inhibitors of matrix me...

Descripción completa

Detalles Bibliográficos
Autores principales:	Saucedo, Lucia, Pfister, Isabel B., Zandi, Souska, Gerhardt, Christin, Garweg, Justus G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8257377/ https://www.ncbi.nlm.nih.gov/pubmed/34257518 http://dx.doi.org/10.1155/2021/9811361

Ejemplares similares

Aqueous Humor Apolipoprotein Concentration and Severity of Diabetic Retinopathy in Type 2 Diabetes
por: Saucedo, Lucia, et al.
Publicado: (2022)

Cytokine profiles in the aqueous humor and serum of patients with dry and treated wet age-related macular degeneration
por: Spindler, Jan, et al.
Publicado: (2018)

Comparison of cytokine profiles in the aqueous humor of eyes with pseudoexfoliation syndrome and glaucoma
por: Garweg, Justus G., et al.
Publicado: (2017)

Adding a Corticosteroid or Switching to Another Anti-VEGF in Insufficiently Responsive Wet Age-Related Macular Degeneration
por: Kaya, Cagdas, et al.
Publicado: (2019)

Association of inflammation-related markers and diabetic retinopathy severity in the aqueous humor, but not serum of type 2 diabetic patients
por: Saucedo, Lucia, et al.
Publicado: (2023)

Risks and Challenges in Interpreting Simultaneous Analyses of Multiple Cytokines
por: Pfister, Isabel B., et al.
Publicado: (2020)

Visual Outcome after Intravitreal Anti-VEGF Therapy for Macular Neovascularisation Secondary to Sorsby’s Fundus Dystrophy: A Systematic Review
por: Baston, Arthur, et al.
Publicado: (2021)

Postoperative proliferative vitreoretinopathy development is linked to vitreal CXCL5 concentrations
por: Zandi, Souska, et al.
Publicado: (2021)

Retinal vein occlusion and the use of a dexamethasone intravitreal implant (Ozurdex®) in its treatment
por: Garweg, Justus G., et al.
Publicado: (2016)

Long-term outcomes of intravitreal therapy for symptomatic diabetic macular oedema in a real-world setting in Switzerland
por: Zirpel, Johanna J., et al.
Publicado: (2021)

Cytokine profiles of phakic and pseudophakic eyes with primary retinal detachment
por: Garweg, Justus G., et al.
Publicado: (2018)

Intraocular matrix metalloproteinase 2 and 9 in patients with diabetes mellitus with and without diabetic retinopathy
por: Kłysik, Anna B., et al.
Publicado: (2010)

Biomarkers for PVR in rhegmatogenous retinal detachment
por: Zandi, Souska, et al.
Publicado: (2019)

Continued anti-VEGF treatment does not prevent recurrences in eyes with stable neovascular age-related macular degeneration using a treat-and-extend regimen: a retrospective case series
por: Garweg, Justus G., et al.
Publicado: (2021)

Disease stability and extended dosing under anti-VEGF treatment of exudative age-related macular degeneration (AMD) — a meta-analysis
por: Garweg, Justus G., et al.
Publicado: (2021)

Matrix Metalloproteinase-2 in the Development of Diabetic Retinopathy and Mitochondrial Dysfunction
por: Mohammad, Ghulam, et al.
Publicado: (2010)

Gene Expression of Matrix Metalloproteinases and their Inhibitors (TIMPs) in Meningiomas of Dogs
por: Mandara, M.T., et al.
Publicado: (2017)

Regulation of Matrix Metalloproteinase-9 by Epigenetic Modifications and the Development of Diabetic Retinopathy
por: Zhong, Qing, et al.
Publicado: (2013)

Dynamic DNA methylation of matrix metalloproteinase-9 in the development of diabetic retinopathy
por: Kowluru, Renu A., et al.
Publicado: (2016)

Brolucizumab in Pretreated Neovascular Age-Related Macular Degeneration: Case Series, Systematic Review, and Meta-Analysis
por: Hänsli, Christof, et al.
Publicado: (2023)

Matrix metalloproteinases and diabetic foot ulcers: the ratio of MMP-1 to TIMP-1 is a predictor of wound healing
por: Muller, M, et al.
Publicado: (2008)

Balance between matrix metalloproteinases (MMP) and tissue inhibitors of metalloproteinases (TIMP) in the cervical mucus plug estimated by determination of free non-complexed TIMP
por: Becher, Naja, et al.
Publicado: (2008)

ROC analysis of selected matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in psoriatic patients
por: Glazewska, Edyta K., et al.
Publicado: (2018)

Matrix metalloproteinase-14 is a biomarker of angiogenic activity in proliferative diabetic retinopathy
por: Abu El-Asrar, Ahmed M., et al.
Publicado: (2018)

Functional Outcomes of Brolucizumab-Induced Intraocular Inflammation Involving the Posterior Segment—A Meta-Analysis and Systematic Review
por: Garweg, Justus G., et al.
Publicado: (2023)

Fibrogenesis and Carcinogenesis in Nonalcoholic Steatohepatitis (NASH): Involvement of Matrix Metalloproteinases (MMPs) and Tissue Inhibitors of Metalloproteinase (TIMPs)
por: Okazaki, Isao, et al.
Publicado: (2014)

Genetic variations and plasma levels of gelatinase A (matrix metalloproteinase-2) and gelatinase B (matrix metalloproteinase-9) in proliferative diabetic retinopathy
por: Beránek, Michal, et al.
Publicado: (2008)

Urine Levels of Matrix Metalloproteinases and Tissue Inhibitor of Metalloproteinases in Children with Type 1 Diabetes Mellitus
por: Yürük Yıldırım, Zeynep, et al.
Publicado: (2019)

Matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in amyotrophic lateral sclerosis (ALS)
por: Łukaszewicz-Zając, Marta, et al.
Publicado: (2014)

Imbalances between Matrix Metalloproteinases (MMPs) and Tissue Inhibitor of Metalloproteinases (TIMPs) in Maternal Serum during Preterm Labor
por: Tency, Inge, et al.
Publicado: (2012)

Matrix metalloproteinases (MMPs) and inhibitor of metalloproteinases (TIMP) mRNA and protein expression in laryngeal squamous cell carcinoma
por: Grzelczyk, Weronika Lucas, et al.
Publicado: (2019)

Outer retinal features in OCT predict visual recovery after primary macula-involving retinal detachment repair
por: Hänsli, Christof, et al.
Publicado: (2022)

miR-122 promotes diabetic retinopathy through targeting TIMP3
por: Wang, Mingliang, et al.
Publicado: (2020)

An evaluation of matrix metalloproteinase-9 (Mmp-9) and tissue inhibitor metalloproteinase-1 (Timp-1) Serum levels and the Mmp-9/Timp-1 Ratio in Covid-19 patients
por: Demir, Nazlim Aktug, et al.
Publicado: (2023)

Altered Matrix Metalloproteinases Expression in Placenta from Patients with Gestational Diabetes Mellitus
por: Ding, Rong, et al.
Publicado: (2018)

Matrix Metalloproteinase-10/TIMP-2 Structure and Analyses Define Conserved Core Interactions and Diverse Exosite Interactions in MMP/TIMP Complexes
por: Batra, Jyotica, et al.
Publicado: (2013)

Expressions of Matrix Metalloproteinases (MMP-2, MMP-7, and MMP-9) and Their Inhibitors (TIMP-1, TIMP-2) in Inflammatory Bowel Diseases
por: Jakubowska, Katarzyna, et al.
Publicado: (2016)

Matrix metalloproteinase MMP-8, TIMP-1 and MMP-8/TIMP-1 ratio in plasma in methicillin-sensitive Staphylococcus aureus bacteremia
por: Forsblom, Erik, et al.
Publicado: (2021)

Matrix Metalloproteinases in Diabetic Kidney Disease
por: Garcia-Fernandez, Nuria, et al.
Publicado: (2020)

Ocular Associations of Diabetes Other Than Diabetic Retinopathy
por: Jeganathan, V. Swetha E., et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_jugakfcv69733ea97ci0tlg2fb